Implementing a Group Physical Therapy Program for Veterans (GroupPT): Function QUERI 3.0
NCT ID: NCT07215572
Last Updated: 2025-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
20 participants
INTERVENTIONAL
2026-10-01
2030-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementing Group Physical Therapy (PT) for Veterans With Knee Osteoarthritis (Group PT): Function QUERI 2.0
NCT05282927
Group Physical Therapy for Knee Osteoarthritis
NCT01058304
Group Physical Therapy for Knee Osteoarthritis
NCT00642772
Telehealth Stepped Exercise Program for Rural Veterans With Knee Osteoarthritis
NCT04775589
STepped Exercise Program for Knee OsteoArthritis
NCT02653768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aims:
Aim 1: Refine foundational REP and Reach+Equity to support implementation of Group PT.
Key Questions: How can the Reach+Equity bundle be optimized to facilitate equitable reach? What are shareholder perspectives on refinements needed for Group PT foundational REP activities, as well as strategies to enhance equitable reach (Reach+Equity bundle)? Aim 2: Evaluate implementation of Group PT with foundational REP versus foundational REP and Reach+Equity. Key Questions: Are there differences in implementation outcomes (reach, fidelity, adoption, cost) at six, 12 and 18 months between arms? Is reach representative of patients experiencing knee OA at participating sites (equitable reach) and does this differ between foundational REP and Reach+Equity arms? Are there differences in effectiveness outcomes (function, pain) between arms? How do sites experience implementation strategies in each arm?
Methodology. To evaluate implementation of Group PT (Aim 2), the investigators will randomize sites (n=20) 1:1 to either foundational support or foundational support plus the Reach+Equity bundle. Implementation activities will occur over a 12-month period. Foundational REP will feature an extensive Implementation Toolkit that includes specific guidance for EBP delivery (e.g., flow of the class, specific exercises, didactic content), along with comprehensive patient resources including videos to guide home exercise. The Reach+Equity bundle will include: 1) external facilitation (provide an outside perspective to help sites identify barriers, develop effective strategies, and navigate complex change processes particularly through the lens of achieving equitable reach); 2) equity in implementation toolkit (guide that supports awareness and consideration of health equity during the implementation process); and 3) equity-focused data-driven monitoring (inform progress regarding equitable reach-related goals). The Group PT sessions includes 6 sessions that include exercise and educational content. Patients will be eligible for Group PT if they have a clinician diagnosis of symptomatic knee OA and ineligible if they have a substantial fall risk or co-occurring health conditions that would make participation in a group exercise class unsafe. The primary follow-up outcome time point will be 18 months; metrics will also be evaluated at 6 and 12 months. Implementation outcomes include: Reach (primary), defined as the number of patients initiating Group PT, Fidelity, defined as the average number of sessions attended by patients who initiate the EBP, and Adoption, defined as launching a Group PT program and enrolling 5 Veterans. Effectiveness Outcomes/Quality Metrics will be collected during the Group PT sessions and documented in the electronic health record. These outcomes include the PROMIS Pain Interference and Function scales, a 30-second chair stand test, and patient satisfaction. Generalized linear models will be used to examine the effect of foundational vs. Reach+Equity on reach and fidelity. Generalized linear mixed effect models will be used to compare effective outcomes between implementation arms.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Foundational Support
Foundational Support uses the Replicating Effective Program (REP) implementation strategy and includes 5 elements that were developed and tested in our prior Function QUERI work: shareholder engagement, Group PT toolkit, Online shared resources (SharePoint) access for clinical program training materials, data reports to assist sites with tracking their data, and Diffusion Networks to promote peer-to-peer sharing and implementation support.
Implementation Strategy: Foundational Support
Foundational Support uses the Replicating Effective Program (REP) implementation strategy and includes 5 elements that were developed and tested in our prior Function QUERI work: shareholder engagement, Group PT toolkit, Online shared resources (SharePoint) access for clinical program training materials, data reports to assist sites with tracking their data, and Diffusion Networks to promote peer-to-peer sharing and implementation support.
Reach+Equity Bundle
The Reach+Equity bundle will include the same activities as foundational support plus the Reach+Equity bundle activities which include: 1) external facilitation (provide an outside perspective to help sites identify barriers, develop effective strategies, and navigate complex change processes particularly through the lens of achieving equitable reach); 2) equity in implementation toolkit (guide that supports awareness and consideration of health equity during the implementation process); and 3) equity-focused data-driven monitoring (inform progress regarding equitable reach-related goals).
Implementation Strategy: Reach+Equity Bundle
The Reach+Equity bundle will include the same activities as foundational support plus the Reach+Equity bundle activities which include: 1) external facilitation (provide an outside perspective to help sites identify barriers, develop effective strategies, and navigate complex change processes particularly through the lens of achieving equitable reach); 2) equity in implementation toolkit (guide that supports awareness and consideration of health equity during the implementation process); and 3) equity-focused data-driven monitoring (inform progress regarding equitable reach-related goals).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implementation Strategy: Foundational Support
Foundational Support uses the Replicating Effective Program (REP) implementation strategy and includes 5 elements that were developed and tested in our prior Function QUERI work: shareholder engagement, Group PT toolkit, Online shared resources (SharePoint) access for clinical program training materials, data reports to assist sites with tracking their data, and Diffusion Networks to promote peer-to-peer sharing and implementation support.
Implementation Strategy: Reach+Equity Bundle
The Reach+Equity bundle will include the same activities as foundational support plus the Reach+Equity bundle activities which include: 1) external facilitation (provide an outside perspective to help sites identify barriers, develop effective strategies, and navigate complex change processes particularly through the lens of achieving equitable reach); 2) equity in implementation toolkit (guide that supports awareness and consideration of health equity during the implementation process); and 3) equity-focused data-driven monitoring (inform progress regarding equitable reach-related goals).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2 outpatient PT clinicians (one primary and one back-up) for delivering Group PT
* space to conduct group sessions (if delivering Group PT in person) or ability to conduct visits via telehealth (video)
Patients will be eligible for Group PT if they have a clinician diagnosis of symptomatic knee OA.
Exclusion Criteria
* Patients will be ineligible for Group PT if they have a substantial fall risk or co-occurring health conditions that would make participation in a group exercise class unsafe.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelli Dominick Allen, PhD
Role: PRINCIPAL_INVESTIGATOR
Durham VA Medical Center, Durham, NC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QUX 25-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.